Risk of psychosis from cannabis use lower than originally thought, say scientists

April 20, 2017
cannabis
Cannabis indica. Credit: Wikipedia

The research, published in the journal, Addiction, also showed for the first time that there is sufficient evidence to demonstrate that for patients who already have schizophrenia, cannabis makes their symptoms worse.

More than two million people in England and Wales used cannabis in the past 12 months, but the latest research shows that banning the drug would have low impact on mental .

In order to prevent just one case of , more than 20,000 people would have to stop using cannabis, as shown by a previous study led by the University of Bristol.

This means that at a population level, an increased risk of psychosis from cannabis use is low, and those vulnerable to developing serious is relatively rare. The research highlights, however, that more reviews on the impact of high potency cannabis is needed in order to make a full assessment of the risks.

Ian Hamilton, lecturer in mental health at the University of York, said: "The link between cannabis and psychosis has been an ongoing research topic since the drug became popular in the 1960s. Most of the high profile studies that we have access to, however, are from a time when low potency cannabis was the norm, but today high potency is more common.

"High potency cannabis contains less of a chemical that is believed to protect against negative side-effects, such as psychosis, and a higher level of a chemical that can trigger psychosis. In this new study, we looked at both low and high potency, but it is clear that we need more evidence from high potency-related health cases to further investigate this link in modern-day users."

Despite this, the research was clear that the more high potency cannabis used, the higher the risk of developing problems, even if they are relatively low in number. For those who already had schizophrenia cannabis exacerbated the symptoms.

The greatest risk to health, however, comes from who combine the drug with tobacco. This exposes young people in particular to tobacco dependency at an early age, increasing the chances of cancers, infections, and other health-related issues.

Previous research at York showed that regulating cannabis use could result in more effective strategies aimed at helping drug users to access the right support and guidance. The policy report illustrated, however, that there is too much uncertainly around treatment regimes in an unregulated market to target the appropriate level of care.

Mr Hamilton said: "Regulation could help reduce the risks to health that cannabis use poses, as a regulated cannabis market would introduce some quality control.

"This would provide users with information about the strength of cannabis on offer, something they usually only discover after exposure in the current unregulated market.

"The public health message about the link between cannabis and psychosis has been a difficult one to communicate, but the evidence still points to the benefits of regulations that seek to advise on the greatest , which currently arise due to tobacco use."

Explore further: Study adds to evidence that high strength cannabis is associated with an increased risk of becoming dependent

More information: Ian Hamilton. Cannabis, psychosis and schizophrenia: unravelling a complex interaction, Addiction (2017). DOI: 10.1111/add.13826

Related Stories

Study adds to evidence that high strength cannabis is associated with an increased risk of becoming dependent

October 22, 2016
New data presented at this year's International Early Psychosis Association (IEPA) meeting in Milan, Italy (20-22 October) adds to accumulating evidence that high-potency cannabis in associated with an increased risk of users ...

Cannabis psychosis, gender matters

July 22, 2015
There has been much research exploring the nature of the relationship between cannabis and psychosis, however the role of gender in relation to cannabis psychosis is less well explored and understood.

Further evidence found for causal links between cannabis and schizophrenia

December 19, 2016
People who have a greater risk of developing schizophrenia are more likely to try cannabis, according to new research, which also found a causal link between trying the drug and an increased risk of the condition.

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

Dose-dependent link between cannabis use, psychosis relapse

September 29, 2016
(HealthDay)—Cannabis use may raise the risk of psychosis relapse, according to a study published online Sept. 28 in JAMA Psychiatry.

Marijuana could help treat drug addiction, mental health

November 16, 2016
Using marijuana could help some alcoholics and people addicted to opioids kick their habits, a UBC study has found.

Recommended for you

Schizophrenia disrupts the brain's entire communication system, researchers say

October 17, 2017
Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

Researchers find a fine timeline between delusion and reality

October 12, 2017
The line between reality and delusion may be just a matter of time, a new Yale study suggests.

Virtual humans work better than current ways to identify post-traumatic stress in soldiers

October 12, 2017
Soldiers are more likely to open up about post-traumatic stress when interviewed by a virtual interviewer than by taking a survey, finds a study published today in open-access journal Frontiers in Robotics and AI. A computer-generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.